Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis.
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
D
D
Barraco
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
T L
TL
Lasho
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
N
N
Gangat
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
C
C
Finke
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Y C
YC
Elala
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
A
A
Pardanani
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
A
A
Tefferi
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D037282:Calreticulin / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D006411:Hematopoiesis, Extramedullary / Q000235:genetics; D006801:Humans; D007964:Leukocytosis / Q000150:complications* / Q000453:epidemiology / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D055728:Primary Myelofibrosis / Q000150:complications* / Q000453:epidemiology / Q000235:genetics / Q000473:pathology; D012189:Retrospective Studies; D055815:Young Adult
C576483:CALR protein, human; D037282:Calreticulin